Clinical Trial Glossary Term

Certain agreements

Information required by the Food and Drug Administration Amendments Act of 2007, Section 801 (FDAAA 801). In general, this is a description of any agreement between the sponsor of a clinical study and the principal investigator (PI) that does not allow the PI to discuss the results of the study or publish the study results in a scientific or academic journal after the study is completed.